EICHOR
● Completed
A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment
Condition: Metastatic Adenocarcinoma of the Pancreas · Sponsor: Ipsen
About this study
The purpose of this study is to look at the efficacy and safety of Irinotecan liposome injection in combination with other approved drugs used for cancer therapy, namely 5 fluorouracil/leucovorin (5FU/LV) plus oxaliplatin compared to nab-paclitaxel + gemcitabine treatment in improving the overall survival of patients not previously treated for metastatic pancreatic cancer.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (200)
| University of Alabama at Birmingham | Birmingham, Alabama, United States | — |
| Banner Health- MD Anderson Cancer Center | Gilbert, Arizona, United States | — |
| Mayo Clinic - Scottsdale | Phoenix, Arizona, United States | — |
| Comprehensive Blood And Cancer Center | Bakersfield, California, United States | — |
| University of California- Irvine Health Cancer Cente | Costa Mesa, California, United States | — |
| City of Hope National Medical Center | Duarte, California, United States | — |
| University of California, Los Angeles (UCLA) | Los Angeles, California, United States | — |
| St. Jude Hospital Yorba Linda dba St. Joseph Heritage Healthcare | Orange, California, United States | — |
| University of California - Irvine Medical Center | Orange, California, United States | — |
| Torrance Memorial Physician Network Cancer Care | Redondo Beach, California, United States | — |
| Sutter Health Sacramento | Sacramento, California, United States | — |
| Presbyterian Intercommunity Hospital (PIH) | Whittier, California, United States | — |
+ 188 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04083235